2-(Chloromethyl)-5-nitroisoindoline-1,3-dione

Catalog No.: 
ACTXZN495
CAS No.: 
54455-37-7
Molecular Formula: 
C9H5ClN2O4
Molecular Weight: 
240.60
2-(Chloromethyl)-5-nitroisoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$233.00InquiryInquiry
5g98%$669.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Chloromethyl)-5-nitroisoindoline-1,3-dione
IUPAC Name2-(chloromethyl)-5-nitroisoindoline-1,3-dione
MDL No.MFCD00059889
Molecular FormulaC9H5ClN2O4
Molecular Weight240.60
SMILESO=C1C2=CC=C([N+](=O)[O-])C=C2C(=O)N1CCl
InChI KeyYXMUGXUCSVUONH-UHFFFAOYSA-N
Synonym1H-Isoindole-1,3(2H)-dione, 2-(chloromethyl)-5-nitro-
CAS No.54455-37-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362-P362+P364

Synthetic Route by SureRoute

1. ACTXZN495 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIEJS693 route compound structure diagram
    ACIEJS69389-40-7In Stock
  4. Then
  5. ACTXZN495 route product structure diagram
    ACTXZN49554455-37-7
Inquiry

2. ACTXZN495 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIEJS693 route compound structure diagram
    ACIEJS69389-40-7In Stock
  4. Then
  5. ACTXZN495 route product structure diagram
    ACTXZN49554455-37-7
Inquiry

3. ACTXZN495 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIEJS693 route compound structure diagram
    ACIEJS69389-40-7In Stock
  4. Then
  5. ACTXZN495 route product structure diagram
    ACTXZN49554455-37-7
Inquiry

Comments (0)